A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Name: A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer
Published: 2020
License: Public Domain

Eisai Inc. · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

breastneoplasms estrogen genes positive receptors

receptors, estrogen, genes, erbb-2, breast neoplasms, h3b-6545, palbociclib, metastatic estrogen receptor-positive, her2-negative breast cancer, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Related documents